These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9769596)
1. The levels of plasma interleukin-2 and soluble interleukin-2R in Behçet's disease: a marker of disease activity. Alpsoy E; Cayirli C; Er H; Yilmaz E J Dermatol; 1998 Aug; 25(8):513-6. PubMed ID: 9769596 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. Evereklioglu C; Er H; Türköz Y; Cekmen M Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429 [TBL] [Abstract][Full Text] [Related]
3. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity. Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852 [TBL] [Abstract][Full Text] [Related]
4. Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease. Uchio E; Matsumoto T; Tanaka SI; Ohno S Clin Exp Rheumatol; 1999; 17(2):179-84. PubMed ID: 10342043 [TBL] [Abstract][Full Text] [Related]
6. Synovial fluid cytokine levels in Behçet's disease. Ertenli I; Kiraz S; Calgüneri M; Celik I; Erman M; Haznedaroglu IC; Kirazli S Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S37-41. PubMed ID: 11760396 [TBL] [Abstract][Full Text] [Related]
7. IL-2/IL-2 antibody immune complex regulates HSV-induced inflammation through induction of IL-2 receptor alpha, beta, and gamma in a mouse model. Choi JY; Choi B; Shim JA; Lee ES; Kim DY; Bang D; Sohn S Immunobiology; 2015 Dec; 220(12):1381-92. PubMed ID: 26213097 [TBL] [Abstract][Full Text] [Related]
8. [Soluble IL-2 receptor levels in rheumatic diseases]. Takaya M; Ichikawa Y; Shimizu H; Uchiyama M; Moriuchi J; Arimori S Ryumachi; 1993 Jun; 33(3):229-34. PubMed ID: 8346465 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome. Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202 [TBL] [Abstract][Full Text] [Related]
10. Increased serum interleukin-32 levels in patients with Behçet's disease. Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461 [TBL] [Abstract][Full Text] [Related]
11. Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapy. Simsek H; Kadayifci A J Int Med Res; 1996; 24(3):239-45. PubMed ID: 8725984 [TBL] [Abstract][Full Text] [Related]
12. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease. Akdeniz N; Esrefoglu M; Keleş MS; Karakuzu A; Atasoy M Ann Acad Med Singap; 2004 Sep; 33(5):596-9. PubMed ID: 15531955 [TBL] [Abstract][Full Text] [Related]
14. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity. Turan B; Gallati H; Erdi H; Gürler A; Michel BA; Villiger PM J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of interleukin 6 and interleukin 10 in Egyptian people with Behcet's disease. Talaat RM; Ashour ME; Bassyouni IH; Raouf AA Immunobiology; 2014 Aug; 219(8):573-82. PubMed ID: 24703990 [TBL] [Abstract][Full Text] [Related]
17. Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin. Brynskov J; Tvede N Gut; 1990 Jul; 31(7):795-9. PubMed ID: 2370014 [TBL] [Abstract][Full Text] [Related]
18. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations. Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361 [TBL] [Abstract][Full Text] [Related]
19. [Serum soluble interleukin-2 receptor levels in uveitis]. Xie C; Huang X; Zhou H; Yang P Yan Ke Xue Bao; 1998 Jun; 14(2):64-5. PubMed ID: 12580032 [TBL] [Abstract][Full Text] [Related]
20. Serum concentration of the soluble interleukin-2 receptor in vitiligo patients. Yeo UC; Yang YS; Park KB; Sung HT; Jung SY; Lee ES; Shin MH J Dermatol Sci; 1999 Apr; 19(3):182-8. PubMed ID: 10215190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]